NMT Logo
    • About NMT Medical
      • Who we are
      • Our History
      • Our Executive Team
      • Scientific Advisory Board
      • Careers
        • Career Opportunities
        • Application for Employment
      • Directions
    • Structural Heart Repair
      • Patent Foramen Ovale
      • Atrial Septal Defect
      • Ventricular Septal Defect
      • FDA Disclaimer
    • NMT Technology
      • Technology Overview
      • Clinical History
      • BioSTAR®
        • Clinical Trials
        • Technology-Approach
      • STARFlex®
        • Clinical Trials
        • Technology Approach
      • CardioSEAL®
        • Technology Approach
    • Patient Education
      • Signs of Stroke
      • 10 Questions to ask your Doctor
      • Patient Guides
        • Brazilian Portuguese
        • Danish
        • Dutch
        • English
        • Finnish
        • French
        • German
        • Italian
        • Norwegian
        • Portuguese
        • Spanish
        • Swedish
      • Patients Videos
    • Medical Professional
      • MRI Safety
      • Presentations
      • Medical Professional Videos
      • Clinical Trials
      • Conference Calendar
      • Instructions for Use
      • Newsletter
        • 2009 clinical trial update
        • Issue 1 2009
        • Issue 2 2009
        • Issue 3 2009
        • Issue 4 2009
        • Issue 1 2010
      • Publications
    • Investors
      • Corporate Profile
      • Stock Information
        • Historic Prices
      • Press Releases
      • Event Calendar
      • Archived Webcasts
      • Presentations
      • Corporate Governance
        • Officers & Directors
        • Governance Documents
        • Committee Composition
      • Annual Reports
      • Annual Meeting and Proxy
      • Clinical Studies
      • Fact Sheet
      • SEC Filings
      • Email Notification
      • Information Request
      • FAQs
    • Contact Us
      • Contact Information
      • Contact Us Form

Technology

  • NMT Technology
    • Technology Overview
    • Clinical History
    • BioSTAR®
      • Clinical Trials
      • Technology-Approach
    • STARFlex®
      • Clinical Trials
      • Technology Approach
    • CardioSEAL®
      • Technology Approach

Publications

What is a PFO?
What is an ASD?
What is a VSD? 

Technology Overview

Since 1986, NMT Medical, Inc. has worked with physicians to pioneer innovative, catheter-based technology to provide a minimally invasive treatment for a range of cardiac defects, such as Patent Foramen Ovale (PFO), Atrial Septal Defects (ASD), and Ventricular Septal Defects (VSD).

BioSTAR® is the world’s first bioabsorbable septal repair implant. 90-95% of the BioSTAR® implant is absorbed and replaced by the patients native tissue providing a natural biological closure of the defect. Learn More

The STARFlex® uses a unique self-centering mechanism, fabricated from a single nitinol coil micro-spring. The micro-spring is attached to alternating sides of the umbrella arm tips and provides a self-adjusting positioning mechanism which assists to centrally locate the implant within the defect. Learn More

The CardioSEAL® works like two tiny spring-loaded umbrellas to cover a hole in the heart. Collapsed, it fits in a catheter that is threaded through veins to reach the heart. Once in position, it is opened and covers both sides of the the hole in the heart. Learn More

 

Quick Links

Conference Calendar
Press Releases
Webcasts 

undefined

"Over time the BioSTAR® scaffold will be replaced with the patient's native tissue."

 

Michael J. Mullen,
MB, BS, MRCP, MD,
Consultant Cardiologist,
The Heart Hospital,
London, United Kingdom

 

Learn More

 

Home | About NMT Medical | Structural Heart Repair | NMT Technology | Patient Education | Medical Professionals
Investors | Contact Us | Privacy Policy | Glossary | Login

All content © 2009 NMT Medical, Inc.
NMT Medical, Inc., 27 Wormwood Street, Boston, MA 02210 | 617.737.0930 
Web Design and Web Development by Wakefly                                                                             ML-0061-03